RSU · 2021. 5. 26. · adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years...

2

Transcript of RSU · 2021. 5. 26. · adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years...

Page 1: RSU · 2021. 5. 26. · adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind placebo-controlled, phase 2 trial. The Lancet
Page 2: RSU · 2021. 5. 26. · adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind placebo-controlled, phase 2 trial. The Lancet